Literature DB >> 17095560

Inhibition of myosin light-chain phosphorylation inverts the birefringence response of porcine airway smooth muscle.

Alexander V Smolensky1, Susan H Gilbert, Margaret Harger-Allen, Lincoln E Ford.   

Abstract

Muscle birefringence, caused mainly by parallel thick filaments, increases in smooth muscle during stimulation, signalling thick filament formation upon activation. The reverse occurs in skeletal muscle, where a decrease in birefringence has been correlated with crossbridge movement away from the thick filaments. When force generation by trachealis muscle was inhibited with wortmannin, which inhibits myosin light-chain phosphorylation and thick-filament formation, but not the calcium increase caused by stimulation, the birefringence response inverted, suggesting crossbridge movement similar to that of skeletal muscle. Resistance to quick stretches was much greater in stimulated muscle than in unstimulated muscle before wortmannin treatment and no different in stimulated and unstimulated muscle after force inhibition by wortmannin. Before wortmannin treatment, stimulation reduced thick-filament cross-sectional areas in electron micrographs by 44%. After force inhibition by wortmannin, filament areas were not significantly different in stimulated and unstimulated muscle and not significantly different from those of relaxed muscle without wortmannin treatment. These results suggest that myofibrillar-space calcium causes crossbridges to move away from the thick filaments without firmly attaching to thin filaments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095560      PMCID: PMC2075147          DOI: 10.1113/jphysiol.2006.122648

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Force and myosin light chain phosphorylation in dog airway smooth muscle activated in different ways.

Authors:  Theodor Burdyga; Richard W Mitchell; Joseph Ragozzino; Lincoln E Ford
Journal:  Respir Physiol Neurobiol       Date:  2003-09-16       Impact factor: 1.931

2.  Vascular smooth muscle calponin. A novel troponin T-like protein.

Authors:  K Takahashi; K Hiwada; T Kokubu
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

3.  Analysis of the birefringence of the smooth muscle anococcygeus of the rat, at rest and in contraction. I.

Authors:  A Godfraind-De Becker; J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1988-02       Impact factor: 2.698

4.  Ca2+, cAMP, and changes in myosin phosphorylation during contraction of smooth muscle.

Authors:  M O Aksoy; S Mras; K E Kamm; R A Murphy
Journal:  Am J Physiol       Date:  1983-09

5.  Evidence for cross-bridge attachment in relaxed muscle at low ionic strength.

Authors:  B Brenner; M Schoenberg; J M Chalovich; L E Greene; E Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Light-chain phosphorylation controls the conformation of vertebrate non-muscle and smooth muscle myosin molecules.

Authors:  R Craig; R Smith; J Kendrick-Jones
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

7.  A note suggesting that the cross-bridge attachment during muscle contraction may take place in two stages.

Authors:  A F Huxley
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-02-27

8.  Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.

Authors:  K Sobue; Y Muramoto; M Fujita; S Kakiuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

9.  Density of myosin filaments in the rat anococcygeus muscle, at rest and in contraction. II.

Authors:  J M Gillis; M L Cao; A Godfraind-De Becker
Journal:  J Muscle Res Cell Motil       Date:  1988-02       Impact factor: 2.698

10.  Effects of phosphorylation, calcium ion, and tropomyosin on actin-activated adenosine 5'-triphosphatase activity of mammalian smooth muscle myosin.

Authors:  S Chacko
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.